Trials / Completed
CompletedNCT01314365
DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia
DYSPORT™ for Injection AbobotulinumtoxinA Neurotoxin Clinical & Health Economics Outcomes Registry in Cervical Dystonia (ANCHOR-CD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 350 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the protocol is to determine typical patient response to Dysport in the treatment of adult cervical dystonia (CD).
Conditions
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2013-11-01
- Completion
- 2014-03-01
- First posted
- 2011-03-14
- Last updated
- 2020-11-05
Locations
45 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01314365. Inclusion in this directory is not an endorsement.